By Aaron Vehling ( November 12, 2014, 4:21 PM EST) -- Braintree Laboratories Inc. has asked the U.S. Supreme Court to consider whether the Federal Circuit must defer to a district court's factual findings for claim construction, urging the justices to review its generic colon cleanser patent dispute, which it says hinges on the justices' forthcoming decision in Teva Pharmaceuticals USA v. Sandoz Inc....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.